HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

HER2 gene-protein assay (GPA) is a new method for the simultaneous evaluation of HER2 immunohistochemistry (IHC) and HER2 dual in situ hybridization (DISH) on single tissue sections of breast cancer. We investigated the presence of HER2 gene and protein discrepancy and HER2-heterogeneity using HER2-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Kurozumi, Sasagu, Padilla, Mary, Kurosumi, Masafumi, Matsumoto, Hiroshi, Inoue, Kenichi, Horiguchi, Jun, Takeyoshi, Izumi, Oyama, Tetsunari, Ranger-Moore, Jim, Allred, D. Craig, Dennis, Eslie, Nitta, Hiroaki
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2016
Assuntos:
Clinical Trial
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4937084/
https://ncbi.nlm.nih.gov/pubmed/27318853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3856-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados